Viridian Therapeutics (VRDN) Metrics: History & Chart

Viridian Therapeutics, Inc.(VRDN)

Biotechnology · Waltham, MA

$18.22-0.78 (-4.11%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc. is a biotechnology firm committed to creating therapies for patients afflicted by serious illnesses. Its primary development efforts include VRDN-001, a humanized monoclonal anti-IGF-1R antibody currently advancing through Phase 1/2 clinical trials for thyroid eye disease (TED). The company's portfolio also features VRDN-002, an IGF-1R antibody undergoing Phase 1 clinical evaluation, alongside VRDN-003, a therapeutic antibody also designed to target IGF-1R for TED. Established in 2006, this Waltham, Massachusetts-based firm previously operated as Miragen Therapeutics, Inc., before changing its name to Viridian Therapeutics, Inc. in January 2021.

Waltham, MA

252 employees

www.viridiantherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Stephen F. Mahoney

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-7.63%
30D Total Return	-17.10%
YTD Total Return	-38.95%
1Y Total Return	-12.24%
3Y Total Return	+30.69%
5Y Total Return	+8.47%
10Y Total Return	-83.34%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-38.95%
2025	+62.34%
2024	-11.98%
2023	-25.44%
2022	+47.75%
2021	+20.18%
2020

CAGR TTM	-12.19%
CAGR 3Y	+9.33%
CAGR 5Y	+1.64%
CAGR 10Y	-16.41%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

VRDN Valuation Metrics

VRDN Stock Price Metrics

VRDN Dividend Metrics

VRDN Growth Rate Metrics

VRDN Discounted Cash Flow Metrics

VRDN Returns By Period

VRDN Yearly Returns

VRDN Average Annual Returns By Period (CAGR)

VRDN Revenue Metrics

VRDN PE Ratio Metrics

VRDN PS Ratio Metrics

VRDN PB Ratio Metrics

VRDN Price to Free Cash Flow Ratio Metrics

VRDN Debt to Equity Ratio Metrics

VRDN PEG Ratio Metrics

VRDN FCF Yield

VRDN Earnings Yield

VRDN EBITDA Yield

VRDN OCF Yield

VRDN EV/EBIT Ratio Metrics

VRDN EV/EBITDA Ratio Metrics

VRDN EV/Assets Ratio Metrics

VRDN EV/Sales Ratio Metrics

VRDN Current Ratio Metrics

VRDN Quick Ratio Metrics

VRDN ROIC Metrics

VRDN Return on Assets Metrics

VRDN Return on Equity Metrics

VRDN Net Profit Margin Metrics

VRDN Gross Profit Margin Metrics

VRDN Tax Rate Metrics

PS Ratio	28.82
PS Ratio Avg TTM	30.48
PS Ratio Avg 3Y	2500.10
Current VS TTM Avg	-5.43%
Current VS 3Y Avg	-98.85%
Current VS 5Y Avg	-98.25%

PB Ratio	3.63
PB Ratio Avg TTM	5.15
PB Ratio Avg 3Y	3.71
Current VS TTM Avg	-29.48%
Current VS 3Y Avg	-2.26%
Current VS 5Y Avg	-11.95%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.37
Debt/Equity Ratio Avg TTM	0.12
Debt/Equity Ratio Avg 3Y	0.05
Current VS TTM Avg	+202.53%
Current VS 3Y Avg	+700.33%
Current VS 5Y Avg	+1011.60%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.94
Ev/Assets Ratio Avg TTM	2.79
Ev/Assets Ratio Avg 3Y	1.92
Current VS TTM Avg	-30.36%
Current VS 3Y Avg	+1.20%
Current VS 5Y Avg	+7.44%

Ev/Sales Ratio	29.91
Ev/Sales Ratio Avg TTM	29.02
Ev/Sales Ratio Avg 3Y	2281.93
Current VS TTM Avg	+3.06%
Current VS 3Y Avg	-98.69%
Current VS 5Y Avg	-98.00%

Current Ratio	16.95
Current Ratio Avg TTM	13.41
Current Ratio Avg 3Y	15.74
Current VS TTM Avg	+26.42%
Current VS 3Y Avg	+7.70%
Current VS 5Y Avg	+20.94%

Quick Ratio	16.95
Quick Ratio Avg TTM	13.41
Quick Ratio Avg 3Y	15.74
Current VS TTM Avg	+26.42%
Current VS 3Y Avg	+7.70%
Current VS 5Y Avg	+20.73%

ROIC	(39.18%)
ROIC Avg 3Y	(52.54%)
ROIC Avg 5Y	(51.14%)
Current VS 3Y Avg	+25.42%
Current VS 5Y Avg	+23.39%
Current VS 10Y Avg	+40.20%

ROA	(35.27%)
ROA Avg TTM	(12.31%)
ROA Avg 3Y	(12.66%)
Current VS TTM Avg	-186.49%
Current VS 3Y Avg	-178.49%
Current VS 5Y Avg	-185.06%

ROE	(58.45%)
ROE Avg TTM	(57.88%)
ROE Avg 3Y	(53.10%)
Current VS TTM Avg	-0.98%
Current VS 3Y Avg	-10.07%
Current VS 5Y Avg	-13.22%

Net Profit Margin	(544.06%)
Net Profit Margin Avg TTM	(68939.70%)
Net Profit Margin Avg 3Y	(84015.37%)
Current VS TTM Avg	+99.21%
Current VS 3Y Avg	+99.35%
Current VS 5Y Avg	+99.06%

Gross Profit Margin	99.55%
Gross Pft Margin Avg TTM	51.52%
Gross Pft Margin Avg 3Y	100.00%
Current VS TTM Avg	+93.24%
Current VS 3Y Avg	-0.45%
Current VS 5Y Avg	+131.05%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%